InvestorsHub Logo
Followers 1
Posts 131
Boards Moderated 0
Alias Born 09/12/2017

Re: Tex18 post# 5295

Monday, 05/20/2019 12:00:34 PM

Monday, May 20, 2019 12:00:34 PM

Post# of 6939
Haha - you added good info about a possible timeline for approval which is consistent with DD I have read - especially with the shortage of BCG. I keep trying to find a reason why FDA would not approve, but am having a hard time - efficacy and safety are better than BCG, definite need for a serious disease which would improve quality of life and delay surgery (responders are approximately 15 times more likely than non-responders to remain cystectomy-free at 2.5 years, an important stat for FDA), likely partnerships in discussion, significant institutional ownership (almost 50%).